Dhaliwal Harpreet S. — SEC insider filings
SEC reporting owner CIK 1886794. 14 insider filings on record with FilingPulse; latest filed 2026-11-13.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2022-02-01 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 3 filings — 43,743 shares, $2,543,062 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
- Largest priced transaction: sale of 17,000 shares @ $55.00 ($935,068) in Vaxcyte, Inc., filed 2026-08-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Vaxcyte, Inc. (PCVX) | Chief Technical Ops Officer | 14 | — | 5 legs · 43,743 sh · $2,543,062 | 23 |
Insider filings — Dhaliwal Harpreet S.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-13 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 17,000 @ $24.79 · Sale (S): 7,135 @ $67.33 · Sale (S): 9,345 @ $68.16 · Sale (S): 520 @ $68.82 · Option exercise (M): 17,000 (derivative) @ $0 | EDGAR |
| 2026-09-09 | 4 | Vaxcyte, Inc. (PCVX) | Tax withholding (F): 7,651 @ $60.36 | EDGAR |
| 2026-09-02 | 4 | Vaxcyte, Inc. (PCVX) | Tax withholding (F): 361 @ $60.74 · Tax withholding (F): 659 @ $61.58 | EDGAR |
| 2026-08-05 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 17,000 @ $24.79 · Sale (S): 17,000 @ $55.00 · Option exercise (M): 17,000 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | Vaxcyte, Inc. (PCVX) | Tax withholding (F): 604 @ $59.32 | EDGAR |
| 2026-03-02 | 4 | Vaxcyte, Inc. (PCVX) | Grant/award (A): 53,409 @ $0 · Tax withholding (F): 292 @ $61.98 · Tax withholding (F): 465 @ $61.98 · Grant/award (A): 46,424 (derivative) @ $0 | EDGAR |
| 2026-01-02 | 4 | Vaxcyte, Inc. (PCVX) | Sale (S): 9,743 @ $46.69 | EDGAR |
| 2025-09-10 | 4 | Vaxcyte, Inc. (PCVX) | Tax withholding (F): 1,204 @ $32.41 | EDGAR |
| 2025-09-04 | 4 | Vaxcyte, Inc. (PCVX) | Tax withholding (F): 291 @ $31.56 · Tax withholding (F): 783 @ $31.56 · Tax withholding (F): 464 @ $31.56 | EDGAR |
| 2023-01-04 | 4 | Vaxcyte, Inc. (PCVX) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2022-12-30 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 3,990 @ $25.06 · Disposition to issuer (D): 3,990 (derivative) @ $0 | EDGAR |
| 2022-09-07 | 4 | Vaxcyte, Inc. (PCVX) | Tax withholding (F): 1,513 @ $26.38 | EDGAR |
| 2022-03-04 | 4 | Vaxcyte, Inc. (PCVX) | Grant/award (A): 17,500 @ $0 · Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2022-02-01 | 4 | Vaxcyte, Inc. (PCVX) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1886794 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs